Publications (137) MARIA ANGELES SOLINIS ASPIAZU publications

filter_list

2025

  1. Asialofetuin-Coupled Lipid-Based nanosystems to target the Asialoglycoprotein receptor: Delivering genes to hepatocytes for the treatment of Fabry disease

    European Journal of Pharmaceutical Sciences, Vol. 210

  2. Cationic Green Solid Lipid nanoparticles by the fatty acid coacervation method for gene delivery to the cornea: preliminary studies on cell and isolated tissue models

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 214

  3. Clinical efficacy, safety and pharmacokinetics of novel β-lactam/β-lactamase inhibitor combinations: a systematic review

    JAC-Antimicrobial Resistance, Vol. 7, Núm. 3

  4. Farmazia komunitarioaren eta lehen mailako arretaren integrazioa Euskal Herrian: aliantza estrategiko bat

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 47, pp. 57-73

  5. Impact of Additional Monitoring on Pharmacovigilance and Pharmacists' Role: A Scoping Review

    Pharmacoepidemiology and Drug Safety, Vol. 34, Núm. 9

2024

  1. Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 885-893

  2. Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells

    Journal of Drug Delivery Science and Technology, Vol. 99

  3. Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach

    Antibiotics, Vol. 13, Núm. 6

  4. Population pharmacokinetics of oral fosfomycin calcium in healthy women

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 11, pp. 2837-2845

  5. Retos en la formación del Grado en Farmacia ante la nueva Directiva europea 2024/782 de 4 de marzo de 2024

    Pharmaceutical Care España, Vol. 26

  6. Service-Learning in the Field of Pharmaceutical Care and Social Pharmacy as a Training Tool to Develop the Final Degree Project

    ICERI Proceedings

  7. Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems

    BioDrugs, Vol. 38, Núm. 5, pp. 657-680

  8. Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review

    Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2615-2628

2023

  1. Absorción de fármacos

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 181-198

  2. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

    Blood Purification, Vol. 52, Núm. 5, pp. 464-473

  3. Eliminación de fármacos

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 217-235

  4. Expression of a conserved sequence of SARS-CoV-2 for panβ-coronavirus vaccine development

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  5. Modelo SoTL para evaluar el aprendizaje basado en la investigación en el desarrollo de TFG sobre atención farmacéutica

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  6. Nanopartículas lipídicas funcionalizadas con GalNAc para suplementación génica: aplicación en la enfermedad de Fabry

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  7. Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease

    Pharmaceutics, Vol. 15, Núm. 7